These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29092891)

  • 1. Sildenafil Is Associated With Reduced Device Thrombosis and Ischemic Stroke Despite Low-Level Hemolysis on Heart Mate II Support.
    Saeed O; Rangasamy S; Selevany I; Madan S; Fertel J; Eisenberg R; Aljoudi M; Patel SR; Shin J; Sims DB; Reyes Gil M; Goldstein DJ; Slepian MJ; Billett HH; Jorde UP
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29092891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil Reduces the Risk of Thromboembolic Events in HeartMate II Patients with Low-Level Hemolysis and Significantly Improves the Pulmonary Circulation.
    Zayat R; Ahmad U; Stoppe C; Khattab MA; Arab F; Moza A; Tewarie L; Goetzenich A; Autschbach R; Schnoering H
    Int Heart J; 2018 Nov; 59(6):1227-1236. PubMed ID: 30305587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
    Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis and Nonhemorrhagic Stroke During Venoarterial Extracorporeal Membrane Oxygenation.
    Saeed O; Jakobleff WA; Forest SJ; Chinnadurai T; Mellas N; Rangasamy S; Xia Y; Madan S; Acharya P; Algodi M; Patel SR; Shin J; Vukelic S; Sims DB; Reyes Gil M; Billett HH; Kizer JR; Goldstein DJ; Jorde UP
    Ann Thorac Surg; 2019 Sep; 108(3):756-763. PubMed ID: 30980824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
    Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and adverse events during continuous flow left ventricular assist device support.
    Saeed O; Jermyn R; Kargoli F; Madan S; Mannem S; Gunda S; Nucci C; Farooqui S; Hassan S; Mclarty A; Bloom M; Zolty R; Shin J; D'Alessandro D; Goldstein DJ; Patel SR
    Circ Heart Fail; 2015 May; 8(3):551-6. PubMed ID: 25870369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
    Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
    Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.
    Xanthopoulos A; Tryposkiadis K; Triposkiadis F; Fukamachi K; Soltesz EG; Young JB; Wolski K; Blackstone EH; Starling RC
    J Am Heart Assoc; 2020 Jul; 9(14):e015897. PubMed ID: 32648508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Ischemic Stroke Following Left Ventricular Assist Device.
    Rettenmaier LA; Garg A; Limaye K; Leira EC; Adams HP; Shaban A
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105384. PubMed ID: 33254382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.